Health Canada
- Status: approved
Rosuvastatin and Ezetimibe morning or evening administration (Rosuvastatin and Ezetimibe morning or evening administration) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Collegium Medicum w Bydgoszczy is the originator. The local marketing authorisation holder may differ — check the official source linked above.